The secret is out: : jdrucker.com is the fastest-growing Drudge-like aggregator in conservative and Christian media.
In this LifeNews article, a pro-life organization is raising alarms that federal regulators are ignoring mounting safety concerns surrounding widely used abortion drugs.
- A pro-life advocacy group is calling out Marty Makary for allegedly failing to address risks tied to abortion pills
- The group argues that adverse event data linked to drugs like mifepristone is being overlooked or downplayed
- Concerns include serious complications such as hemorrhaging, infections, and emergency hospital visits
- Critics say the U.S. Food and Drug Administration has relaxed safety protocols, including reducing in-person medical oversight
- The article highlights claims that reporting requirements for complications have been weakened over time
- Advocates are urging greater transparency and stricter regulation to better inform women of potential risks
- The controversy reflects broader national debates over abortion policy and drug safety oversight
Read the full story: https://www.lifenews.com/2026/05/04/pro-life-group-wants-fda-commissioner-marty-makary-for-ignoring-aboriton-drug-problems/
